ATRC · AtriCure, Inc.
AI read · Good for ATRC
The AI's read
Broader use of several products helped lift U.S. sales 17%. AtriCure also reported quarterly net income. BOX NOAF and LeAAPS could expand its reach, but trial results have not arrived yet.
AtriCure's sales rose 15% to $154.5 million, and it reported $4 million in net income. BOX NOAF results are still pending, but sales growth and its 2026 sales forecast support a stronger outlook.
Broader use of several products helped lift U.S. sales 17%. AtriCure also reported quarterly net income. BOX NOAF and LeAAPS could expand its reach, but trial results have not arrived yet.
Follow AtriCure, Inc. (ATRC) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ATRC